Department of Precision Health

Keyphrases

1. Luxembourg 100%
2. Novel Food 97%
3. COVID-19 55%
4. Europe 50%
5. Parkinson's Disease 40%
6. Obesity 35%
7. Meta-analysis 33%
8. Physical Activity 33%
9. Global Burden of Disease Study 32%
10. Cardiovascular Disease 31%
11. Carotenoids 30%
12. MicroRNA 30%
13. Scoping Review 29%
14. Knee 29%
15. Diabetes 29%
16. Anterior Cruciate Ligament Injury 27%
17. Risk Factors 25%
18. Cardiovascular Risk Factors 25%
19. Type 2 Diabetes Mellitus (T2DM) 24%
20. Anterior Cruciate Ligament Reconstruction 23%
21. Polycyclic Aromatic Hydrocarbons 23%
22. France 23%
23. 95% Confidence Interval 22%
24. Pesticides 22%
25. Body Mass Index 22%
26. Hair Analysis 22%
27. Randomized Controlled Trial 21%
28. Comorbidity 20%
29. Running Injury 20%
30. Heart Failure 20%
31. Type 1 Diabetes Mellitus (T1DM) 20%
32. Type I Diabetes 19%
33. Hypertension 19%
34. Non-coding RNA (ncRNA) 18%
35. Older Adults 18%
36. Myocardial Infarction 17%
37. Anterior Cruciate Ligament 17%
38. Metabolic Syndrome 17%
39. Injury Risk 17%
40. Long Non-coding RNA (LncRNA) 17%
41. Dietary Inflammatory Index 16%
42. Population-based Study 16%
43. Odds Ratio 16%
44. β-carotene 16%
45. Clinical Practice 15%
46. Health Claims 15%
47. Acute Myocardial Infarction 15%
48. European Countries 15%
49. Cardiac Arrest 15%
50. Food Allergens 14%
51. European Commission 14%
52. ACL Reconstruction 14%
53. Chronic Disease 14%
54. Quality of Life 13%
55. Vitamins 13%
56. Food Supplements 13%
57. Biomonitoring 13%
58. Extension of Use 13%
59. Ramp Lesion 13%
60. Injury Prevention 13%
61. Type 2 Diabetes Risk 13%
62. Machine Learning 12%
63. Meniscus 12%
64. Clinical Trials 12%
65. High Risk 12%
66. Vocal Biomarkers 12%
67. Hair Samples 12%
68. Disability-adjusted Life Years 12%
69. Dietary Intake 12%
70. Blood Pressure 12%
71. Population-based 11%
72. Mental Health 11%
73. Inflammation 11%
74. Sports Injury 11%
75. Use Conditions 11%
76. Shoes 11%
77. Medial Meniscus 11%
78. Artificial Intelligence 11%
79. Pregnant Women 11%
80. Adenosine 11%
81. Long COVID 11%
82. Healthcare 11%
83. Clinical Outcomes 11%
84. Tolerable Upper Intake Level 11%
85. Scoping Review Protocol 10%
86. Knee Surgery 10%
87. Hazard Ratio 10%
88. Prospective Cohort Study 10%
89. Confidence Interval 10%
90. Breast Cancer 10%
91. Zinc 10%
92. Luxembourgish 10%
93. ESSKA 10%
94. Pooled Analysis 10%
95. Overweight/obesity 9%
96. Outcome Prediction 9%
97. Scientific Opinion 9%
98. Article 13 9%
99. Diabetes Management 9%
100. Dietary Patterns 9%